Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060677) titled 'Immune Analysis of Endometrial Cancer' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University
Condition:
Condition - Endometrial cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to characterize tumor-infiltrating lymphocytes (TILs) in patients with endometrial cancer, including the impact of reagents on their immunological profiles.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - 1. Patients who visit the institution between the date of approval by the head of the research institution and March 31, 2027.
2. Patients with a diagnosis or radiological suspicion of endometrial cancer, who are in good general condition and scheduled for tissue collection, such as via surgical resection.
3. Patients from whom written informed consent for study participation can be obtained based on their own free will.
4. Patients aged 18 years or older at the time of providing consent. No upper age limit is set as long as criterion 4 is met.
Key exclusion criteria - 1. Women who are pregnant or may be pregnant.
2. Patients judged by their primary physician to be unsuitable for tissue collection or study participation.
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 01 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069402
Disclaimer: Curated by HT Syndication.
